Heidi Fuller

Professor Heidi Fuller serves as Head of School for Pharmacy and Bioengineering and Professor of Medical Science at Keele University, leading research at the Wolfson Centre for Inherited Neuromuscular Disease (RJAH Orthopaedic Hospital). Her dual institutional roles bridge academic leadership with translational neuromuscular research.

Her educational foundation includes:

• BSc in Biomolecular Science, University of Wales, Bangor (with NHS research scholarship)
• PhD in Proteomics Technology, University of Wales, North East Wales Institute (industry-sponsored)

Research focuses on severe muscle-wasting diseases using integrated proteomics-bioinformatics approaches. Her team investigates muscular dystrophy and spinal muscular atrophy mechanisms to identify druggable pathways, with particular emphasis on cardiac complications and nuclear envelope defects in LMNA-related disorders. This work combines biochemical validation with computational analysis for therapeutic target discovery.

Publication trends (2021-2025) reveal consistent neuromuscular disease focus, with 80% of articles addressing spinal muscular atrophy or muscular dystrophy. Key themes include proteomic biomarker discovery (40%), cardiac/systemic complications (25%), and gene therapy optimization (20%). The 2021 Viking anatomy study represents an interdisciplinary outlier.

She actively supervises postgraduate researchers across Medicine and Pharmacy disciplines, previously directing MMedSci programs (2016-2021) and serving as Dean of Education (2021-2024). Her leadership spans curriculum development, educational strategy, and student mentorship.

Her research group operates from the Wolfson Centre's dedicated facilities at RJAH Orthopaedic Hospital, maintaining close hospital-university collaboration for patient-focused neuromuscular research.